Literature DB >> 7788851

Cells transfected with transferrin receptor cDNA lacking the iron regulatory domain become more sensitive to the DNA-damaging action of oxidative stress.

A L Nascimento1, R Meneghini.   

Abstract

Chinese hamster V79 cells were transfected with human transferrin receptor cDNA, lacking the 3' untranslatable regulatory sequence. One of the clones obtained was investigated completely. It exhibited the cDNA sequences recombined into the genome, transcribed the corresponding mRNA and became partially constitutive in iron uptake from transferrin. The rate of iron uptake was significantly higher in these cells than in the parental ones, as was the intracellular iron content, assessed indirectly by measuring the activation of the regulatory protein responsible for iron homeostasis control. The transfected cells were more sensitive to the DNA-damaging action of H2O2. This corroborates the important role that iron plays as a mediator of DNA damage by reactive oxygen species. It also points to the possibility that mutations at the regulatory sequences of transferrin receptors, leading to partial disturbance in iron homeostasis, might render the cells more prone to further mutations and malignant transformations by reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7788851     DOI: 10.1093/carcin/16.6.1335

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

Review 1.  The molecular basis of asbestos induced lung injury.

Authors:  D W Kamp; S A Weitzman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 2.  Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.

Authors:  H Wiseman; B Halliwell
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

3.  Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer.

Authors:  S Shigeta; M Toyoshima; K Kitatani; M Ishibashi; T Usui; N Yaegashi
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.